These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12362877)

  • 1. [Coversyl again].
    Jacobsen K
    Ugeskr Laeger; 2002 Sep; 164(37):4300; author reply 4300-1. PubMed ID: 12362877
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics.
    Cardiovasc J Afr; 2008; 19(4):226. PubMed ID: 18776973
    [No Abstract]   [Full Text] [Related]  

  • 3. [Type 2 diabetes. Routine ACE inhibitors?].
    Hönl SB
    Med Monatsschr Pharm; 2008 Apr; 31(4):149-50. PubMed ID: 18497249
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.
    You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS
    J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PROGRESS trial three years later: time for more action, less distraction.
    Macmahon S; Neal B; Rodgers A; Chalmers J
    BMJ; 2004 Oct; 329(7472):970-1. PubMed ID: 15499117
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood pressure and stroke; the PROGRESS trial.
    He FJ; MacGregor GA
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):153-5. PubMed ID: 11881116
    [No Abstract]   [Full Text] [Related]  

  • 7. Invited commentary. Stroke preventive treatment using perindopril and indapamide in the context of Indian primary care.
    Wennberg RA; Zimmermann C
    Neurol India; 2007; 55(2):101-2. PubMed ID: 17558107
    [No Abstract]   [Full Text] [Related]  

  • 8. Secondary prevention for stroke and transient ischaemic attacks.
    Muir KW
    BMJ; 2004 Feb; 328(7435):297-8. PubMed ID: 14764462
    [No Abstract]   [Full Text] [Related]  

  • 9. Stroke prevention: indapamide, a forgotten option?
    Parra Ruiz J; Muñoz Medina L; Miras Parra F; de la Higuera Torres-Puchol JM
    Stroke; 2003 Sep; 34(9):e156-7; author reply e156-7. PubMed ID: 12947159
    [No Abstract]   [Full Text] [Related]  

  • 10. You should treat patients over the age of 80 who have hypertension.
    Lundberg GD
    Medscape J Med; 2008; 10(8):185. PubMed ID: 18924637
    [No Abstract]   [Full Text] [Related]  

  • 11. Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension.
    Neglia D; Fommei E; Varela-Carver A; Mancini M; Ghione S; Lombardi M; Pisani P; Parker H; D'amati G; Donato L; Camici PG
    J Hypertens; 2011 Feb; 29(2):364-72. PubMed ID: 21045728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
    Gosse P
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PROGRESS trial three years later: time for a balanced report of effectiveness.
    Wennberg R; Zimmermann C
    BMJ; 2004 Oct; 329(7472):968-70. PubMed ID: 15499116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive therapy in diabetic patients. What do the new data mean for the practice?].
    Holzgreve H
    MMW Fortschr Med; 2007 Sep; 149(38):19. PubMed ID: 18018408
    [No Abstract]   [Full Text] [Related]  

  • 16. Converting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients with stroke history and renal dysfunction?
    Fournier A; Godefroy O; Oprisiu R; Slama M; Andrejak M
    Stroke; 2003 Jan; 34(1):8-9; author reply 8-9. PubMed ID: 12511742
    [No Abstract]   [Full Text] [Related]  

  • 17. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
    Nilsson PM
    Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
    [No Abstract]   [Full Text] [Related]  

  • 18. [Correction of endothelial dysfunction by noliprel in patients with metabolic syndrome].
    Trusov VV; Filimonov MA; Aksenov KV
    Kardiologiia; 2005; 45(5):55-6. PubMed ID: 16007054
    [No Abstract]   [Full Text] [Related]  

  • 19. Coversyl plus--when monotherapy is not enough.
    Cardiovasc J S Afr; 2001; 12(3):179-80. PubMed ID: 11710312
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardioprotective effects of anti-hypertensive medications].
    Asmar RG
    Curr Med Res Opin; 2005; 21 Suppl 5():S17-21. PubMed ID: 16197648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.